×
About 77,324 results

ALLMedicine™ Antiretroviral Therapy Center

Research & Reviews  37,443 results

Long-acting injectable HIV therapies: the next frontier: Republication.
https://doi.org/10.1097/COH.0000000000000670
Current Opinion in HIV and AIDS; Thornhill J, Orkin C

Feb 24th, 2021 - There has been significant development of long-acting injectable therapy for the management of HIV in recent years that has the potential to revolutionise HIV care as we know it. This review summarises the data and outlines the potential challenge...

Genetic Associations with Weight Gain among South Africans who Initiated Dolutegravir- ...
https://doi.org/10.1097/QAI.0000000000002661
Journal of Acquired Immune Deficiency Syndromes (1999); Cindi Z, Maartens G et. al.

Feb 24th, 2021 - Excessive weight gain affects some HIV-positive individuals prescribed dolutegravir- containing regimens. Mechanisms underlying such weight gain are unknown. Data and DNA from antiretroviral therapy-naïve participants who were randomized to initia...

High population-attributable fractions of traditional risk factors for non-AIDS-definin...
https://doi.org/10.1080/22221751.2021.1894904
Emerging Microbes & Infections; Liu J, Hou Y et. al.

Feb 23rd, 2021 - Morbidity and mortality of non-AIDS-defining diseases (NADs) have become the increasing burden of people living with HIV (PLWH) with long-term antiretroviral therapy (ART). We aimed to quantify the contribution of modifiable risk factors to NADs. ...

Expression of Human Immunodeficiency Virus Transactivator of Transcription (HIV-Tat1-86...
https://doi.org/10.1007/s11481-021-09985-4 10.1096/fj.10-162313 10.1016/j.cyto.2014.11.001 10.1002/jnr.10762 10.1038/sj.jcbfm.9600115 10.1186/1743-422X-10-358 10.1002/ejp.1618 10.1016/0304-3959(88)90209-6 10.1177/1756285614564152 10.1371/journal.pone.0024412 10.1523/JNEUROSCI.3045-16.2017 10.3389/fphar.2019.00678 10.1016/j.neuron.2007.04.017 10.3389/fnmol.2017.00284 10.1016/j.neulet.2008.12.062 10.3389/fncel.2014.00302 10.1016/j.ejphar.2012.05.029 10.3791/51012 10.1007/s11904-007-0017-6 10.2174/1570159X11311050005 10.1097/QAD.0000000000002268 10.1136/bmj.324.7335.466 10.1073/pnas.1308673110 10.1021/jm500989n 10.1007/s13365-014-0236-8 10.1016/S0002-9440(10)64304-0 10.1248/bpb.32.651 10.1073/pnas.1009926107 10.1073/pnas.1009926107 10.1007/s13365-017-0598-9 10.1016/j.neulet.2016.12.073 10.1007/s13365-019-00757-8 10.1007/s11064-019-02824-2 10.1016/S1090-3801(02)00053-8 10.1016/S0006-8993(00)02050-3 10.1523/JNEUROSCI.21-08-02808.2001 10.18773/austprescr.2018.022 10.1097/j.pain.0000000000000171 10.1016/j.bbr.2015.05.021 10.1016/0091-3057(88)90243-2 10.1016/j.bbi.2019.03.011 10.1371/journal.pone.0014433 10.1016/j.pain.2014.06.014 10.1016/S1044-7431(03)00171-4 10.1016/j.brainres.2007.09.063 10.1093/infdis/jix013 10.1208/s12248-010-9191-3 10.1080/13550280701200102 10.1038/jcbfm.2011.197 10.1523/JNEUROSCI.2851-18.2019 10.1523/JNEUROSCI.3195-17.2018 10.1007/s11481-020-09951-6 10.1038/nn.4053 10.1002/glia.23768 10.1097/PR9.0000000000000654 10.1038/s41598-020-71073-z 10.1523/JNEUROSCI.5552-03.2004 10.1002/ana.24139
Journal of Neuroimmune Pharmacology : the Official Journa... Cirino TJ, Alleyne AR et. al.

Feb 23rd, 2021 - Despite the success of combined antiretroviral therapy (cART) in reducing viral load, a substantial portion of Human Immunodeficiency Virus (HIV)+ patients report chronic pain. The exact mechanism underlying this co-morbidity even with undetectabl...

Disclosure Concerns and Viral Suppression in People Newly Initiating HIV Care: The Role...
https://doi.org/10.1097/QAI.0000000000002593 10.1037/xge0000788
Journal of Acquired Immune Deficiency Syndromes (1999); Yigit I, Bayramoglu Y et. al.

Feb 23rd, 2021 - Research on how disclosure concerns affect health outcomes for people living with HIV (PLWH) has yielded inconsistent results. Theoretically, disclosure concerns could predict either poorer antiretroviral therapy (ART) adherence (PLWH worried abou...

see more →

Guidelines  121 results

Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy Era
https://jamanetwork.com/journals/jamaoncology/article-abstract/2757078
JAMA Oncology; Calkins KL,et al

Dec 4th, 2019 - What is the association between cancer treatment and CD4 count and HIV RNA level, and how are these markers associated with all-cause mortality among people with HIV?

Preexposure Prophylaxis for the Prevention of HIV Infection: Recommendation Statement
https://www.aafp.org/afp/2019/1115/od1.html
AAFP

Nov 16th, 2019 - Summary of Recommendation and Evidence The USPSTF recommends that clinicians offer preexposure prophylaxis (PrEP) with effective antiretroviral therapy to persons who are at high risk of HIV acquisition (Table 1). A recommendation.

Subclinical Cardiovascular Disease in HIV Controller & Long‐term Nonprogressor Populations
https://onlinelibrary.wiley.com/doi/abs/10.1111/hiv.12820
HIV Medicine; Brusca RM,et al

Nov 13th, 2019 - Elite controllers (ECs), viraemic controllers (VCs), and long‐term nonprogressors (LTNPs) control HIV viral replication or maintain CD4 T‐cell counts without antiretroviral therapy, but may have increased cardiovascular disease (CVD) risk compared...

Screening for HIV Infection in Asymptomatic, Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
https://jamanetwork.com/journals/jama/fullarticle/2735343
JAMA US Preventive Services Task Force

Jun 10th, 2019 - Importance Untreated HIV infection can result in significant morbidity, mortality, and HIV transmission. A 2012 review for the US Preventive Services Task Force (USPSTF) found antiretroviral therapy (ART) associated with improved clinical outcome...

Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force
https://jamanetwork.com/journals/jama/fullarticle/2735508
JAMA US Preventive Services Task Force

Jun 10th, 2019 - Importance Effective prevention strategies for HIV infection are an important public health priority. Preexposure prophylaxis (PrEP) involves use of antiretroviral therapy (ART) daily or before and after sex to decrease risk of acquiring HIV infe...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  38,423 results

Long-acting injectable HIV therapies: the next frontier: Republication.
https://doi.org/10.1097/COH.0000000000000670
Current Opinion in HIV and AIDS; Thornhill J, Orkin C

Feb 24th, 2021 - There has been significant development of long-acting injectable therapy for the management of HIV in recent years that has the potential to revolutionise HIV care as we know it. This review summarises the data and outlines the potential challenge...

Genetic Associations with Weight Gain among South Africans who Initiated Dolutegravir- ...
https://doi.org/10.1097/QAI.0000000000002661
Journal of Acquired Immune Deficiency Syndromes (1999); Cindi Z, Maartens G et. al.

Feb 24th, 2021 - Excessive weight gain affects some HIV-positive individuals prescribed dolutegravir- containing regimens. Mechanisms underlying such weight gain are unknown. Data and DNA from antiretroviral therapy-naïve participants who were randomized to initia...

High population-attributable fractions of traditional risk factors for non-AIDS-definin...
https://doi.org/10.1080/22221751.2021.1894904
Emerging Microbes & Infections; Liu J, Hou Y et. al.

Feb 23rd, 2021 - Morbidity and mortality of non-AIDS-defining diseases (NADs) have become the increasing burden of people living with HIV (PLWH) with long-term antiretroviral therapy (ART). We aimed to quantify the contribution of modifiable risk factors to NADs. ...

Expression of Human Immunodeficiency Virus Transactivator of Transcription (HIV-Tat1-86...
https://doi.org/10.1007/s11481-021-09985-4 10.1096/fj.10-162313 10.1016/j.cyto.2014.11.001 10.1002/jnr.10762 10.1038/sj.jcbfm.9600115 10.1186/1743-422X-10-358 10.1002/ejp.1618 10.1016/0304-3959(88)90209-6 10.1177/1756285614564152 10.1371/journal.pone.0024412 10.1523/JNEUROSCI.3045-16.2017 10.3389/fphar.2019.00678 10.1016/j.neuron.2007.04.017 10.3389/fnmol.2017.00284 10.1016/j.neulet.2008.12.062 10.3389/fncel.2014.00302 10.1016/j.ejphar.2012.05.029 10.3791/51012 10.1007/s11904-007-0017-6 10.2174/1570159X11311050005 10.1097/QAD.0000000000002268 10.1136/bmj.324.7335.466 10.1073/pnas.1308673110 10.1021/jm500989n 10.1007/s13365-014-0236-8 10.1016/S0002-9440(10)64304-0 10.1248/bpb.32.651 10.1073/pnas.1009926107 10.1073/pnas.1009926107 10.1007/s13365-017-0598-9 10.1016/j.neulet.2016.12.073 10.1007/s13365-019-00757-8 10.1007/s11064-019-02824-2 10.1016/S1090-3801(02)00053-8 10.1016/S0006-8993(00)02050-3 10.1523/JNEUROSCI.21-08-02808.2001 10.18773/austprescr.2018.022 10.1097/j.pain.0000000000000171 10.1016/j.bbr.2015.05.021 10.1016/0091-3057(88)90243-2 10.1016/j.bbi.2019.03.011 10.1371/journal.pone.0014433 10.1016/j.pain.2014.06.014 10.1016/S1044-7431(03)00171-4 10.1016/j.brainres.2007.09.063 10.1093/infdis/jix013 10.1208/s12248-010-9191-3 10.1080/13550280701200102 10.1038/jcbfm.2011.197 10.1523/JNEUROSCI.2851-18.2019 10.1523/JNEUROSCI.3195-17.2018 10.1007/s11481-020-09951-6 10.1038/nn.4053 10.1002/glia.23768 10.1097/PR9.0000000000000654 10.1038/s41598-020-71073-z 10.1523/JNEUROSCI.5552-03.2004 10.1002/ana.24139
Journal of Neuroimmune Pharmacology : the Official Journa... Cirino TJ, Alleyne AR et. al.

Feb 23rd, 2021 - Despite the success of combined antiretroviral therapy (cART) in reducing viral load, a substantial portion of Human Immunodeficiency Virus (HIV)+ patients report chronic pain. The exact mechanism underlying this co-morbidity even with undetectabl...

Disclosure Concerns and Viral Suppression in People Newly Initiating HIV Care: The Role...
https://doi.org/10.1097/QAI.0000000000002593 10.1037/xge0000788
Journal of Acquired Immune Deficiency Syndromes (1999); Yigit I, Bayramoglu Y et. al.

Feb 23rd, 2021 - Research on how disclosure concerns affect health outcomes for people living with HIV (PLWH) has yielded inconsistent results. Theoretically, disclosure concerns could predict either poorer antiretroviral therapy (ART) adherence (PLWH worried abou...

see more →

News  1,329 results

Prenatal HIV-ART Exposure May Contribute to Cardiac Changes in Babies
https://www.medscape.com/viewarticle/945010

Feb 1st, 2021 - NEW YORK (Reuters Health) - HIV uninfected infants exposed to antiretroviral therapy (ART) before birth may have "relevant" cardiovascular changes, report clinicians in Spain. "Subclinical cardiac impairment together with higher blood pressure and...

The Changing Brain Signature of HIV
https://www.medscape.com/viewarticle/944659

Jan 24th, 2021 - Combination antiretroviral therapy (cART) has shifted HIV infection from a fatal to a chronic condition. New evidence now suggests this has been accompanied by a shift in the profile of HIV-related brain abnormalities beyond the basal ganglia, fre...

COVID-19 Infection Linked to Detectable Viral Levels in HIV Patients on ART
https://www.medscape.com/viewarticle/941874

Dec 2nd, 2020 - NEW YORK (Reuters Heath) - People with HIV who have recovered from COVID-19 infection are more likely to have detectable levels of HIV-1 RNA in their plasma than individuals with HIV but no SARS-CoV-2 co-infection, according to new research. Highl...

Aging With HIV Adds to Comorbidity Burden
https://www.staging.medscape.com/viewarticle/940525

Nov 5th, 2020 - The age of antiretroviral therapy (ART) for HIV is in its third decade, and many of the patients who live in areas of the world fortunate enough to have had early access to therapy have now lived for several decades with complications of HIV and v...

Aging With HIV Adds to Comorbidity Burden
https://www.medscape.com/viewarticle/940525

Nov 5th, 2020 - The age of antiretroviral therapy (ART) for HIV is in its third decade, and many of the patients who live in areas of the world fortunate enough to have had early access to therapy have now lived for several decades with complications of HIV and v...

see more →

Patient Education  1 results see all →